This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Based in Chicago, IL, and founded in 1973, Cboe Global Markets, Inc. (effective Oct 17, 2017, CBOE Holdings, Inc. came to be known as Cboe Global Markets, Inc.) is one of the largest stock exchange operators by volume in the United States and a leading market globally for ETP trading. Cboe offers trading across a diverse range of products in multiple asset classes and geographies, including options, futures, U.S. and European equities, exchange-traded products (ETPs), global foreign exchange (FX) and multi-asset volatility products based on the VIX Index. Cboe’s trading venues include the largest options exchange in the United States and the largest stock exchange by value traded in Europe
MarketAxess Banks on High Revenues & Strong Capital Position
by Zacks Equity Research
MarketAxess (MKTX) is poised to benefit from strong revenues, robust trading volumes and sound liquidity position.
As the VIX Falls, It's Time To Consider Buying Options
by David Borun
With the VIX back at 30% even as uncertainty lurks, the Straddle is looking like a good bet.
Cboe Global (CBOE) Q1 Earnings & Revenues Top Estimates
by Zacks Equity Research
Cboe Global's (CBOE) Q1 results reflect increased trading activity, decline in expenses and operational efficiencies.
CBOE Holdings (CBOE) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
CBOE (CBOE) delivered earnings and revenue surprises of 7.14% and 1.07%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Cboe Global (CBOE) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Cboe Global's (CBOE) first-quarter 2020 performance is likely to have benefited from acquisition and lower expenses, offset by lower transaction fees.
CBOE Holdings (CBOE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CBOE (CBOE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nasdaq (NDAQ) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Nasdaq's (NDAQ) Q1 results reflect growth in Market Services, Corporate Services, Information Services and Market Technology segments.
Stocks Continue to Rally as Coronavirus Cases Level Off
by David Borun
Fiscal and monetary stimuli help push US equities higher amid signs the curve is flattening.
Will Cboe Global Markets Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor Cboe Global Markets
Zacks.com featured highlights include: Regency Centers, ResMed, Synopsys, Cboe Global Markets and The Southern Company
by Zacks Equity Research
Zacks.com featured highlights include: Regency Centers, ResMed, Synopsys, Cboe Global Markets and The Southern Company
Sales Growth Makes These 5 Stocks Good Bets Amid Coronavirus Woes
by Swayta Shah
Amid coronavirus-related market mayhem and economic slowdown, sales growth can be considered by investors as a reliable metric for selecting profitable stocks.
CME Group's (CME) Volumes for March & Q1 Solid, Increase Y/Y
by Zacks Equity Research
CME Group's (CME) average daily volume for March and first-quarter 2020 increases on the back of better contribution by all six product lines.
Cboe Global's (CBOE) March Average Daily Volume Increases Y/Y
by Zacks Equity Research
Cboe Global's (CBOE) Options, Futures U.S. Equities, European Equities and Global Forex volume reflect y/y increases in March.
3 Stocks Immune to the Coronavirus Downturn to Buy Right Now
by Benjamin Rains
Today's episode of Full Court Finance here at Zacks quickly dives into why Wall Street seems optimistic on Monday. Despite the positivity, investors should still be on the hunt for stocks that appear immune to the broader coronavirus fallout...
Intercontinental Exchanges (ICE) March Volume Improves Y/Y
by Zacks Equity Research
Intercontinental Exchange's (ICE) March volume indicates improved Financial ADV, Commodities ADV and Energy ADV.
Buy Nasdaq (NDAQ) Stock for Safety Amid Coronavirus Market Volatility?
by Benjamin Rains
Nasdaq (NDAQ) shares have surged roughly 30% in the last two weeks and its earnings revisions have climbed amid the broader coronavirus economic downturn...
MarketAxess (MKTX) Reports Solid March Volume Statistics
by Zacks Equity Research
MarketAxess (MKTX) reports impressive volume data for March 2020.
Why the Earnings Surprise Streak Could Continue for CBOE (CBOE)
by Zacks Equity Research
CBOE (CBOE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is Cboe Global Markets (CBOE) Stock a Solid Choice Right Now?
by Zacks Equity Research
Cboe Global Markets (CBOE) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Put Protection is Too Expensive for Your Portfolio
by David Borun
High implied volatilities make buying option protection a poor idea right now.
MarketAxess Rides on Growth in Electronic Trading Network
by Zacks Equity Research
MarketAxess (MKTX) is poised for long-term growth on the back of a structural shift in fixed income markets and the blooming electronic trading market.
Equities Rally, but the VIX Remains High
by David Borun
Factors other than fear can often keep implied volatilities higher than you might guess.
CME Group to Launch Gold Futures Contract Amid Coronavirus Crisis
by Zacks Equity Research
CME Group (CME) unveils gold futures contract with expanded delivery options to settle the disruption in bullion trading.
Cboe Global Markets Enters Oversold Territory
by Zacks Equity Research
Cboe Global Markets has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Nasdaq Warns of Market Manipulation Amid Coronavirus Outbreak
by Zacks Equity Research
Nasdaq (NDAQ) warns of potential market manipulation driven by coronavirus concerns.